These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 321823)

  • 1. Prevention of hyaline membrane disease with plasminogen. A cooperative study.
    Ambrus CM; Choi TS; Cunnanan E; Eisenberg B; Staub HP; Weintraub DH; Courey NG; Patterson RJ; Jockin H; Pickren JW; Bross ID; Jung OS; Ambrus JL
    JAMA; 1977 Apr; 237(17):1837-41. PubMed ID: 321823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of hyaline membrane disease with plasminogen. Preliminary report of a cooperative study.
    Ambrus CM; Choi TS; Cunnanan E; Eisenberg B; Staub HP
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):195-8. PubMed ID: 788079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen in the prevention of hyaline membrane disease.
    Ambrus CM; Weintraub DH; Choi TS; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Bross ID; Jung OS; Mink IB; Ambrus JL
    Am J Dis Child; 1974 Feb; 127(2):189-94. PubMed ID: 4589496
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the prevention of respiratory distress syndrome of infants due to hyaline membrane disease with plasminogen.
    Ambrus CM; Choi TS; Weintraub DH; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Bross ID; Jung OS; Mink IB; Ambrus JL
    Semin Thromb Hemost; 1975 Jul; 2(1):42-51. PubMed ID: 798269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen in the prevention of hyaline membrane disease.
    Ambrus CM; Weintraub DH; Choi TS; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Irwin ; Bross DJ; Jung OS; Mink IB; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):341-4. PubMed ID: 4582209
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in the fibrinolysin system in infantile and adult respiratory distress syndrome (ARDS), caused by trauma and/or septic shock in patients and in experimental animals.
    Ambrus JL; Ambrus CM
    J Med; 1990; 21(1-2):67-84. PubMed ID: 2145377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibrinolytic enzyme defect of hyaline membrane disease.
    LIEBERMAN J; KELLOGG F
    Calif Med; 1961 Nov; 95(5):278-82. PubMed ID: 14465183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways of fibrin turnover in lavage of premature baboons with hyperoxic lung injury.
    Idell S; Kumar A; Koenig KB; Coalson JJ
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):767-75. PubMed ID: 8118648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants.
    Kwong MS; Egan EA; Notter RH; Shapiro DL
    Pediatrics; 1985 Oct; 76(4):585-92. PubMed ID: 3900906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
    Liggins GC; Howie RN
    Pediatrics; 1972 Oct; 50(4):515-25. PubMed ID: 4561295
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hyaline membrane disease with the plasminogen urokinase combination].
    Leroux B; Rose JP; Potron G; Grun G; Droulle C; Mesmin F; Gomes H
    Nouv Presse Med; 1976 Mar; 5(11):699-702. PubMed ID: 772595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.
    Viscardi RM; Broderick K; Sun CC; Yale-Loehr AJ; Hessamfar A; Taciak V; Burke KC; Koenig KB; Idell S
    Am Rev Respir Dis; 1992 Aug; 146(2):492-9. PubMed ID: 1489146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary epithelial permeability in hyaline-membrane disease.
    Jefferies AL; Coates G; O'Brodovich H
    N Engl J Med; 1984 Oct; 311(17):1075-80. PubMed ID: 6384782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variations of plasminogen in newborn and premature infants].
    Potron G; Leroux B; Bertignon C; Graftiaux A
    Arch Fr Pediatr; 1972; 29(6):583-92. PubMed ID: 4672950
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrin degradation products and plasminogen in newborn infants with respiratory disturbances and postnatal asphyxia.
    Ekelund H; Finnström O
    Acta Paediatr Scand; 1972 Nov; 61(6):661-9. PubMed ID: 5080645
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-atelectasis factor (surfactant) and hyaline membrane disease in premature infants].
    Saule H
    Med Klin; 1975 Mar; 70(10):409-15. PubMed ID: 1091827
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental studies on proteolysis of hyaline membranes in vitro (author's transl)].
    Harms D; Buss G; Heimburger N; Pape GR
    Klin Wochenschr; 1975 Dec; 53(24):1147-53. PubMed ID: 1214451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind study.
    Wauer RR; Schmalisch G; Menzel K; Schröder M; Müller K; Tiller R; Methfessel G; Sitka U; Koepke E; Plath C; Schlegel C; Böttcher M; Köppe I; Fricke U; Severin K; Jacobi R; Schmidt W; Hinkel GK; Nitz I; Kunze D; Reichmann G; Lachmann B; Lampe K; Grauel EL
    Int J Biol Res Pregnancy; 1982; 3(2):84-91. PubMed ID: 7042592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New theory of fibrinolytic mechanism in the development of hyaline membrane disease in newborn infants].
    Uszyńska-Folejewska R; Uszyński M
    Pediatr Pol; 1975 Dec; 50(12):1513-5. PubMed ID: 127976
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary epithelial permeability in hyaline membrane disease.
    Kumar RK
    N Engl J Med; 1985 Feb; 312(9):585-6. PubMed ID: 3969126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.